Solid Biosciences to Participate at Upcoming Investor Conferences
Provided By GlobeNewswire
Last update: Mar 5, 2025
CHARLESTOWN, Mass., March 05, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced participation in the following investor conferences:
Read more at globenewswire.com
